1. Tudurachi, Bogdan-Sorin, Zăvoi, Alexandra, Leonte, Andreea, Sascău, Radu Andy, Stătescu, Cristian. 2023. An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy. In International journal of molecular sciences, 24, . doi:10.3390/ijms241310510. https://pubmed.ncbi.nlm.nih.gov/37445689/
2. Ito, Kaoru, Patel, Parth N, Gorham, Joshua M, Seidman, Christine E, Seidman, J G. 2017. Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. In Proceedings of the National Academy of Sciences of the United States of America, 114, 7689-7694. doi:10.1073/pnas.1707741114. https://pubmed.ncbi.nlm.nih.gov/28679633/
3. Carrier, Lucie. 2020. Targeting the population for gene therapy with MYBPC3. In Journal of molecular and cellular cardiology, 150, 101-108. doi:10.1016/j.yjmcc.2020.10.003. https://pubmed.ncbi.nlm.nih.gov/33049255/
4. Helms, Adam S, Thompson, Andrea D, Glazier, Amelia A, Ho, Carolyn Y, Day, Sharlene M. 2020. Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy. In Circulation. Genomic and precision medicine, 13, 396-405. doi:10.1161/CIRCGEN.120.002929. https://pubmed.ncbi.nlm.nih.gov/32841044/
5. Ma, Hong, Marti-Gutierrez, Nuria, Park, Sang-Wook, Kaul, Sanjiv, Mitalipov, Shoukhrat. 2017. Correction of a pathogenic gene mutation in human embryos. In Nature, 548, 413-419. doi:10.1038/nature23305. https://pubmed.ncbi.nlm.nih.gov/28783728/
6. Viswanathan, Shiv Kumar, Sanders, Heather K, McNamara, James W, Tajik, A Jamil, Sadayappan, Sakthivel. 2017. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. In PloS one, 12, e0187948. doi:10.1371/journal.pone.0187948. https://pubmed.ncbi.nlm.nih.gov/29121657/
智鼠故事 
